AVERY ERIKSSON: Open Payments
NPI 1780194530 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,478 in 67 payments from 21 companies in 2025. Trend: 2023 $1,719 · 2024 $1,486 · 2025 $1,478
Food & beverage: $1,478
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $342 |
| Novo Nordisk Inc | 8 | $181 |
| ABBVIE INC. | 9 | $176 |
| GlaxoSmithKline, LLC. | 4 | $89 |
| Xeris Pharmaceuticals, Inc. | 1 | $76 |
| Janssen Pharmaceuticals, Inc | 2 | $62 |
| Lilly USA, LLC | 4 | $61 |
| Astellas Pharma US Inc | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
Products named: NURTEC ODT, TRELEGY ELLIPTA, Wegovy, QULIPTA, REXULTI, KEVEYIS, VRAYLAR, SPRAVATO.
Industry payments across VA — which companies pay providers there.
